Sophia Genetics

BOSTON, LAUSANNE, BORDEAUX, and MARSEILLE – FEBRUARY 1, 2022 – SOPHiA GENETICS (Nasdaq: SOPH), a leader in Data-Driven Medicine, have announced, in conjunction with Assises de Génétique, an extension of their partnership with Institut Paoli Calmettes (IPC), one of the 18 French Comprehensive Cancer Centers (CLCC), to further support the implementation, automatization, and accreditation of solid tumor …

Institut Paoli Calmettes Extends Partnership with SOPHiA GENETICS Read More »

BOSTON and LAUSANNE, Switzerland, January 26, 2022 — SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and knowledge sharing platform that democratizes data-driven medicine, today announced that Ken Freedman has been appointed Chief Revenue Officer. With a background in serving some of the most innovative providers of technology to the world-wide media space, Ken brings more than 25 …

SOPHiA GENETICS Appoints Ken Freedman as Chief Revenue Officer Read More »

Study leverages deep learning-enabled analysis of the aggregation of real-world multimodal data to validate predictive signatures associated with response to immunotherapy and prognosis of patients with stage IV non-small cell lung cancer Since study launch, 12 sites across 5 countries have already signed up for participation   READ MORE

BOSTON and LAUSANNE, Switzerland, January 10, 2022 — SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine, announced key additions to their leadership team with the hiring of Peter Casasanto as Chief BioPharma Officer and Abhimanyu (Abhi) Verma as Chief Technology Officer. The additions are part of SOPHiA GENETICS’ …

Executive Team Hires at SOPHiA GENETICS to Enhance BioPharma Business Read More »

BOSTON (MA), United States and LAUSANNE, Switzerland, Dec 29, 2021 — SOPHiA GENETICS SA (Nasdaq: SOPH), announced today Chief Executive Officer and Co-Founder Dr. Jurgi Camblong and Chief Financial Officer Ross Muken, will participate in the upcoming 40th Annual J.P. Morgan Healthcare Conference. The virtual presentation will begin at 8:15 a.m. ET/2:15 p.m. CET on Tuesday, January …

SOPHiA GENETICS to Present at the 40th Annual J.P. Morgan Healthcare Conference Read More »

BOSTON and LAUSANNE, Switzerland, Oct. 28, 2021 (GLOBE NEWSWIRE) — SOPHiA GENETICS SA (Nasdaq: SOPH) today announced the company will be participating virtually in the following investor conferences: Credit Suisse 30th Annual Healthcare Conference; Fireside Chat on Thursday, November 11th at 2:40pm ET / 8:40pm CET Piper Sandler 33rd Annual Healthcare Conference; Presentation available on demand beginning …

SOPHiA GENETICS to Participate in Upcoming November Investor Conferences Read More »

Symposium to address how new AI-powered analytic and workflow solutions for clinical and biopharma markets are advancing data-driven medicine Symposium encapsulates SOPHiA GENETICS and GE Healthcare alliance to provide joint solutions and multimodal analytics to healthcare providers and biopharma companies CHICAGO, November 29, 2021 — SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and …

SOPHiA GENETICS Hosts Symposium with GE Healthcare at RSNA 2021 Read More »

Study to leverage deep learning-enabled analysis of the aggregation of real-world multimodal data to validate predictive signatures associated with response to immunotherapy and prognosis of patients with stage IV non-small cell lung cancer Large-scale, multicentric real-world study aims to enroll 4,000 patients from approximately 30 sites across North America, Europe, and Latin America BOSTON and LAUSANNE, Switzerland, December 1, …

SOPHiA GENETICS Reports Third Quarter 2021 Financial Results and Raises 2021 Guidance Read More »

Symposium to address how new AI-powered analytic and workflow solutions for clinical and biopharma markets are advancing data-driven medicine Symposium encapsulates SOPHiA GENETICS and GE Healthcare alliance to provide joint solutions and multimodal analytics to healthcare providers and biopharma companies CHICAGO, November 29, 2021 — SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and …

SOPHiA GENETICS Hosts Symposium with GE Healthcare at RSNA 2021 Read More »

Third quarter year-over-year revenue growth of 45%; executed Master Alliance Agreement with GE Healthcare BOSTON and LAUSANNE, Switzerland, November 10, 2021 — SOPHiA GENETICS SA (Nasdaq: SOPH), today reported financial results for the third quarter ended September 30, 2021. Recent Highlights Revenue was $10.4 million for the third quarter, representing a 45% increase over the corresponding …

SOPHiA GENETICS Reports Third Quarter 2021 Financial Results and Raises 2021 Guidance Read More »